Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. IFRX
IFRX logo

IFRX

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IFRX News

InflaRx Completes $150 Million Underwritten Offering

2d agoNewsfilter

InflaRx Scheduled to Announce Q1 Earnings on May 7

4d agoseekingalpha

InflaRx Prices Underwritten Offering of 75M Shares at $2.00 Each

4d agoseekingalpha

InflaRx N.V. Prices 75 Million Share Offering at $2.00 Each

4d agoNewsfilter

InflaRx Unveils New Pre-Clinical Data on Izicopan

6d agoNewsfilter

InflaRx to Release Q1 2026 Financial Results on May 7

May 01 2026Newsfilter

InflaRx Regains Compliance with Nasdaq Minimum Bid Price

Apr 28 2026seekingalpha

InflaRx Regains Compliance with Nasdaq Listing Requirements

Apr 28 2026Newsfilter

InflaRx's Izicopan Shows No Time-Dependent CYP3A4 Inhibition

Apr 09 2026Newsfilter

InflaRx to Participate in Biotech Innovation Symposium

Mar 31 2026Newsfilter

InflaRx Scheduled to Announce FY Earnings Results

Mar 18 2026seekingalpha

InflaRx Receives Nasdaq Non-Compliance Notice

Mar 16 2026NASDAQ.COM

InflaRx Receives Nasdaq Warning for Non-Compliance

Mar 13 2026seekingalpha

InflaRx to Participate in Global Healthcare Conference

Feb 26 2026Newsfilter

iFOREX Officially Lists on London Stock Exchange

Feb 25 2026Businesswire

InflaRx to Participate in Investor Conferences

Jan 29 2026Newsfilter